Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India

Thread starter International: Top News And Analysis
Start date Apr 10, 2026

International: Top News And Analysis

Guest

Apr 10, 2026

Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India

Prefix: N/A

Forum: World News

Start date: Apr 10, 2026

Last reply date: Apr 10, 2026

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Apr 10, 2026

Replies: 0

Views: 8

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search